0001104659-14-074940.txt : 20141029
0001104659-14-074940.hdr.sgml : 20141029
20141029184224
ACCESSION NUMBER: 0001104659-14-074940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141027
FILED AS OF DATE: 20141029
DATE AS OF CHANGE: 20141029
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-0102
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Public Joint Stock Co Pharmstandard
CENTRAL INDEX KEY: 0001598754
STATE OF INCORPORATION: 1Z
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 141181204
BUSINESS ADDRESS:
STREET 1: LIKHACHEVSKY DRIVE
STREET 2: 5 "B"
CITY: DOLGOPRUDNY
STATE: 1Z
ZIP: 141701
BUSINESS PHONE: 7 495 970 0032
MAIL ADDRESS:
STREET 1: LIKHACHEVSKY DRIVE
STREET 2: 5 "B"
CITY: DOLGOPRUDNY
STATE: 1Z
ZIP: 141701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pharmstandard International S.A.
CENTRAL INDEX KEY: 0001598762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 141181205
BUSINESS ADDRESS:
STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-1528
BUSINESS PHONE: 352 26449 557
MAIL ADDRESS:
STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-1528
4
1
a4.xml
4
X0306
4
2014-10-27
0
0001359931
PROTEON THERAPEUTICS INC
PRTO
0001598762
Pharmstandard International S.A.
65 BOULEVARD GRANDE DUCHESSE CHARLOTTE
LUXEMBOURG
N4
L-1528
LUXEMBOURG
0
0
1
0
0001598754
Public Joint Stock Co Pharmstandard
LIKHACHEVSKY DRIVE
5 "B"
DOLGOPRUDNY
1Z
141701
RUSSIAN FEDERATION
0
0
1
0
Common Stock
2014-10-27
4
P
0
600000
10.00
A
600000
D
Common Stock
2014-10-27
4
C
0
565344
A
1165344
D
Series D Convertible Preferred Stock
2014-10-27
4
C
0
8493925
0
D
Common Stock
535218
0
D
Option (Right to Purchase)
2014-10-27
4
J
0
6795140
D
Series D Convertible Preferred Stock
428175
0
D
These shares were purchased in connection with the Issuer's initial public offering of Common Stock.
The shares are held by Pharmstandard International S.A. ("Pharmstandard"). Pharmstandard is a wholly owned subsidiary of Public Joint Stock Company "Pharmstandard". As the parent entity, Public Joint Stock Company "Pharmstandard" has sole voting power and investment control over the shares.
Upon the closing of the Issuer's initial public offering, each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-for-one basis (without payment of further consideration and with no expiration date) plus an additional 30,126 incremental shares as a result of an adjustment as provided for in the Company's certificate of incorporation.
Reflects a 1-for-15.87 reverse stock split effected on October 6, 2014.
Pharmstandard had a right to purchase shares of Series D Convertible Preferred Stock under the Series D Purchase Agreement at a price of $0.588656, which right to purchase ceased to be exercisable upon the initial filing of the Issuer's registration statement for its initial public offering, and terminated upon the completion of the Issuer's initial public offering of Common Stock. Each share of Series D Preferred Stock issuable upon exercise of the right to purchase would have been convertible into shares of the Issuer's common stock as described in footnote (3) above.
By: Pharmstandard International S.A. /s/ Gerard Birchen /s/ Nicolas Gasztoniyi By: Public Joint Stock Company ''Pharmstandard'' /s/ Igor Krylov
2014-10-29